Johnson Pharmacare Limited has provided prior intimation of a Board of Directors meeting scheduled for Wednesday, 27th May, 2026. The meeting will be held at the company's registered office at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad City, Gujarat, India, 380009.
The primary agenda for the meeting is to consider and approve the Audited Financial Results of the Company for the Quarter and year ended on 31st March, 2026.
The company has also disclosed that the Trading Window has been closed since 01st April, 2026 and will remain closed until the completion of 48 hours after the declaration of the audited Financial Results for the quarter and year ended 31st March, 2026.
The notification is made pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015. The communication is signed by Nand Kishor Ray, Additional Director (DIN: 11626638) on behalf of the Board of Directors.